Skip to main content
. 2022 Oct 7;28(10):1412–1420. doi: 10.1089/tmj.2021.0590

Table 1.

Participant Characteristics

  ENTIRE SAMPLE
  BASELINE DEPRESSION SYMPTOMS (PHQ-9 ≥ 10)
BASELINE ANXIETY SYMPTOMS (GAD-7 ≥ 8)
N = 6,738   N = 3,955 N = 6,044
Age, mean (SD) 33.23 (8.75) 33.28 (8.89) 33.22 (8.69)
Gender, n (%)
 Female 4,378 (64.97) 2,548 (64.42) 3,937 (65.14)
 Male 2,353 (34.92) 1,401 (35.42) 2,100 (34.75)
 Missing 7 (0.10) 6 (0.15) 7 (0.12)
Race and Ethnicity, n (%)
 Non-minoritized Group
  White 3,048 (45.24) 1,707 (43.16) 2,717 (44.95)
 Minoritized Groups
  Asian or Pacific Islander 1,761 (26.14) 1,050 (26.55) 1,579 (26.13)
  Black or African American 349 (5.18) 220 (5.56) 309 (5.11)
  Hispanic or Latino 599 (8.89) 375 (9.48) 549 (9.08)
  Multiple 527 (7.82) 324 (8.19) 470 (7.78)
  Other 158 (2.34) 90 (2.28) 142 (2.35)
 Prefer not to disclose/missing 296 (4.39) 189 (4.78) 278 (4.60)
Baseline PHQ-9, mean (SD) 10.73 (5.04) 14.08 (3.53) 10.50 (5.19)
Baseline GAD-7, mean (SD) 11.90 (4.05) 12.22 (4.63) 12.66 (3.51)
No. of therapy sessions completed, mean (SD) 6.00 (3.55) 6.13 (3.66) 6.03 (3.58)
Duration of care (week), mean (SD) 7.58 (6.20) 7.71 (6.37) 7.61 (6.24)

GAD-7, Generalized Anxiety Disorder-7; PHQ-9, Patient Health Questionnaire-9; SD, standard deviation.